Information-based sample size re-estimation in group sequential design for longitudinal trials
- PMID: 24797715
- DOI: 10.1002/sim.6192
Information-based sample size re-estimation in group sequential design for longitudinal trials
Abstract
Group sequential design has become more popular in clinical trials because it allows for trials to stop early for futility or efficacy to save time and resources. However, this approach is less well-known for longitudinal analysis. We have observed repeated cases of studies with longitudinal data where there is an interest in early stopping for a lack of treatment effect or in adapting sample size to correct for inappropriate variance assumptions. We propose an information-based group sequential design as a method to deal with both of these issues. Updating the sample size at each interim analysis makes it possible to maintain the target power while controlling the type I error rate. We will illustrate our strategy with examples and simulations and compare the results with those obtained using fixed design and group sequential design without sample size re-estimation.
Keywords: adaptive design; group sequential design; information; longitudinal data analysis; sample size re-estimation.
Copyright © 2014 John Wiley & Sons, Ltd.
Similar articles
-
Operating characteristics of sample size re-estimation with futility stopping based on conditional power.Stat Med. 2006 Oct 15;25(19):3348-65. doi: 10.1002/sim.2455. Stat Med. 2006. PMID: 16345019
-
Sample size re-estimation in group-sequential response-adaptive clinical trials.Stat Med. 2003 Dec 30;22(24):3843-57. doi: 10.1002/sim.1677. Stat Med. 2003. PMID: 14673942
-
Sample size re-estimation for adaptive sequential design in clinical trials.J Biopharm Stat. 2008;18(6):1184-96. doi: 10.1080/10543400802369053. J Biopharm Stat. 2008. PMID: 18991116
-
Vasopressors and the search for the optimal trial design.Contemp Clin Trials. 2011 Nov;32(6):924-30. doi: 10.1016/j.cct.2011.07.010. Epub 2011 Jul 23. Contemp Clin Trials. 2011. PMID: 21807122 Review.
-
Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.Eur J Cancer. 2012 Jun;48(9):1386-91. doi: 10.1016/j.ejca.2011.12.024. Epub 2012 Jan 24. Eur J Cancer. 2012. PMID: 22281098 Review.
Cited by
-
Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.Stat Med. 2016 Feb 10;35(3):325-47. doi: 10.1002/sim.6472. Epub 2015 Mar 16. Stat Med. 2016. PMID: 25778935 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical